
Induction of protective and therapeutic anti-cancer immunity by using bispecific anti-idiotype antibody G22-I50 for nasopharyngeal carcinoma
Keywords: آنتی بادی Anti-idiotype; Anti-idiotype antibody; Bispecific; Nasopharyngeal carcinoma; hu-PBL–SCID